Results 231 to 240 of about 3,901,448 (262)

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Multiple evolutionary routes to immune diversification across animals. [PDF]

Int Immunol
Taguchi M, de La Forest Divonne S, Morimoto R.   +2 more
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Extracellular pneumolysin enhances the activation of cytosolic pattern-recognition receptor NOD2 through its pore-forming activity. [PDF]

Microbiol Spectr
Domon H, Hirayama S, Isono T, Maekawa T, Terao Y.   +4 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

PGPR-Mediated Plant Immunity: From Microbial Recognition to Epigenetic Priming. [PDF]

Plants (Basel)
Unal D, Satimova S, Botirova D, Muhammad M, Egamberdieva D.   +4 more
europepmc   +1 more source

Unveiling the sensing potential of innate lymphoid cells. [PDF]

Commun Biol
Castillo-González R, Sancho-Temiño L, Seguí-Pérez A, Sciumè G, Stojanović I, Cruz-Adalia A.   +5 more
europepmc   +1 more source

Insect immune systems: same same but different but still same. [PDF]

Front Immunol
Cardoso-Jaime V, Maya-Maldonado K, Powell S, Tikhe CV.   +3 more
europepmc   +1 more source

Molecular recognition in plant root endosymbiosis. [PDF]

Plant J
Fougner-Økland T, Spezzati M, Parys K.
europepmc   +1 more source

GrassSV - hybrid method to detect structural variants in high throughput DNA-seq data. [PDF]

PLoS Comput Biol
Witczak D, Sychla K, Wysocka J, Laskowski A, Frohmberg W, Glowacka M, Dzik A, Lukasiak P, Blazewicz J, Swiercz A.   +9 more
europepmc   +1 more source